This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

OrthoApnea, Vivisol patent dispute with Belgian inventor valued at EUR250,000

( September 17, 2024, 15:16 GMT | Official Statement) -- MLex Summary: OrthoApnea and Jozef Frans Nelissen have seen the Unified Patent Court determine the cost valuation of the patent infringement dispute between the two parties at 250,000 euros, according to an order published by the Brussels UPC court today. The valuation aligns with the court's minimum threshold for such cases, despite objections from the defendants, who argued it was insufficient to reflect the costs already incurred. The procedural order also allowed the use of physical exhibits.Court order attached (in Dutch)....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections